🇺🇸 FDA
Patent

US 8592402

Compounds as lysophosphatidic acid receptor antagonists

granted A61KA61K31/42A61K31/4427

Quick answer

US patent 8592402 (Compounds as lysophosphatidic acid receptor antagonists) held by AMIRA PHARMACEUTICALS, INC. expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AMIRA PHARMACEUTICALS, INC.
Grant date
Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/42, A61K31/4427, A61P, A61P1/16